Research and Development

The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …

Takeda UK has appointed Craig Adkins as the new director of its its inflammatory bowel disease (IBD) business unit. Adkins …

Recent legislation assumes that visual information can have direct effects on people’s behaviour. It starts from the assumption that a …

Virgo Health Education has appointed a new head of medical education and announced a number of senior team promotions.  Katherine …

US-based medical device firm OrthoAccel Technologies has announced that Len Hedge has joined its board of directors.  Hedge currently serves on the …

AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …

Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …

San Diego’s Applied Proteomics that develops protein-based molecular diagnostics has confirmed the appointment of Erwin Estigarribia as the VP of …

AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …

Irish pharma firm Shire has appointed a new chief financial officer and member of its executive committee in Jeff Poulton. …

Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …

GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …

Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …

Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …